Quick Answer
Zymeworks Inc. reported Diluted EPS of $1.08 per share (loss) for fiscal year 2025.
Zymeworks Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.08 | +33.3% |
| 2024 | -$1.62 | +5.8% |
| 2023 | -$1.72 | -190.5% |
| 2022 | $1.90 | +141.2% |
| 2021 | -$4.61 | -28.8% |
| 2020 | -$3.58 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.26 | +33.3% | -966.7% |
| June 30, 2025 | $0.03 | +106.1% | +110.0% |
| March 31, 2025 | -$0.30 | +28.6% | +23.1% |
| September 30, 2024 | -$0.39 | +4.9% | +20.4% |
| June 30, 2024 | -$0.49 | +35.5% | -16.7% |
| March 31, 2024 | -$0.42 | -13.5% | -2.4% |
| September 30, 2023 | -$0.41 | +43.1% | +46.1% |
| June 30, 2023 | -$0.76 | +21.6% | -105.4% |
- Zymeworks Inc. showed an increase of +33.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Zymeworks Inc.’s diluted eps has grown by 69.8% (from $3.58 per share (loss) to $1.08 per share (loss)).
- The most recent figure is from Zymeworks Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: